Goal Ferritin Levels in Adults Without CKD
For adults without chronic kidney disease, target ferritin levels should be maintained at ≥100 ng/mL to ensure adequate iron stores, with iron deficiency defined as ferritin <45 ng/mL based on optimal diagnostic sensitivity and specificity.
Diagnostic Thresholds
The most recent high-quality evidence establishes clear ferritin cutoffs for diagnosing iron deficiency in non-CKD populations:
- Iron deficiency diagnosis: Ferritin <45 ng/mL provides 85% sensitivity and 92% specificity for detecting iron deficiency 1
- This threshold maximizes case detection while minimizing false positives, superior to the older <15 ng/mL cutoff which has only 59% sensitivity 1
Treatment Targets
Once iron deficiency is identified, the goal is iron repletion:
- Target ferritin for repletion: >100 ng/mL 2, 3
- This represents the threshold where iron stores are considered adequate across most clinical conditions
- Iron supplementation should continue until ferritin exceeds 100 ng/mL to restore body iron stores 2
Important Context and Caveats
The provided guidelines are primarily CKD-focused and recommend maintaining ferritin ≥100 ng/mL with TSAT ≥20% 4. However, these targets were developed specifically for CKD patients receiving erythropoietin therapy, where functional iron deficiency is common.
For non-CKD populations, the approach differs:
- Inflammatory conditions: Ferritin is an acute phase reactant and may be falsely elevated with inflammation 1. In these cases, consider adjunctive tests like TSAT, C-reactive protein, or soluble transferrin receptor
- Upper safety limits: While CKD guidelines suggest not exceeding ferritin 500-800 ng/mL 4, recent data in healthy older adults shows reference ranges up to 440-740 ng/mL without adverse outcomes 5
Clinical Algorithm
- Screen for iron deficiency: Ferritin <45 ng/mL confirms diagnosis 1
- Initiate iron supplementation: Oral iron is first-line for most non-CKD patients (200 mg elemental iron daily for adults) 4
- Monitor response: Recheck ferritin after iron supplementation trial
- Target achievement: Continue supplementation until ferritin >100 ng/mL 2
- Maintenance monitoring: Continue hemoglobin monitoring after target achieved 2
Critical distinction: The ferritin targets in CKD patients (≥100 ng/mL minimum, often maintained 200-500 ng/mL) reflect ongoing losses and ESA therapy requirements 4, 6. In non-CKD adults, achieving >100 ng/mL represents adequate repletion without need for higher maintenance targets unless ongoing losses exist.